Alliance Organizational Structure. Trini Ajazi, MM Alliance Chief Administrative Officer Clinical Research Professional Orientation

Similar documents
National Cancer Institute Clinical Trial Cooperative Groups

REPORT. A Model Clinical Trials System for the 21st Century

National Cancer Institute

Diversity Clinical Research Workshop Invited Faculty

DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014

Outcomes & Opportunities through Collaborating in Clinical Trials

Georgia Cancer Quality Information Exchange

Cancer Center Support Grant

AMERICAN JOURNAL OF PUBLIC HEALTH EDITOR-IN-CHIEF

Update of Cancer Programs. Scott H. Kurtzman, MD FACS

The National Cancer Institute Community Oncology Research Program (NCORP) A Local Story

Lymphoma Committee Alliance for Clinical Trials in Oncology 2016 Beijing International Lymphoma Conference April 9, 2016 David J. Straus, M.D.

CCDR Committee Updates. George J Chang, MD MS Health Outcomes Committee May 14, 2016

Children s Oncology Group: What We Learned In The Merger Process

NCIC CTG Overview and Opportunities. Ralph Meyer Director, NCIC CTG

ROLE OF PRMS FROM START TO FINISH. Tricia Adrales Bentz, MHA Hollings Cancer Center

Instructions for Completing the UVMCC Clinical Research Protocol Submission Form UVMCC CLINICAL RESEARCH PROTOCOL SUBMISSION FORM

Sustain and Seize Cancer Research Opportunities

Making a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:

Strategic Operational Research Plan February 13, Scientific Office Digestive Health Strategic Clinical Network

SAMHSA: A Public Health Agency

OVAC FY 2017 Appropriations Requests

Section #3: Process of Change

IOM-ASCO Workshop. Cooperative Group Chairs Report. March 21, Jan Buckner, MD. Mayo Clinic Rochester, MN

The National Accreditation Program for Breast Centers American Program Considerations. Maurício Magalhães Costa Cary S. Kaufman February 9, 2012

NRG ONCOLOGY SEMIANNUAL MEETING FINAL AGENDA Manchester Grand Hyatt San Diego, California February

NACCHO COMMITTEES AND WORKGROUPS

A World Free From Cancer. BC Cancer Foundation 2011 Report to Donors

ONTARIO CANCER PLAN

RECENT TRENDS. The Impact of the NCI and NIBIB

OFFICE OF THE CHANCELLOR OFFICE OF THE VICE CHANCELLOR FOR RESEARCH

IMPACT APA STRATEGIC PLAN

LeadingAge and Hospice Members: Partners in Providing Quality Care to Older Adults. January 2019

NACCHO COMMITTEES AND WORKGROUPS

Washington, DC Washington, DC Washington, DC Washington, DC 20510

Clinical Research Unit Charter

NRG ONCOLOGY SEMIANNUAL MEETING PRELIMINARY AGENDA Phoenix Convention Center Phoenix, Arizona February 7 9, 2019

NEWS. Alliance Membership Model, Governance Structure Now Set. Alliance for Clinical Trials in Oncology

Down Syndrome Association of Atlanta Position Description

Leadership Council Roles & Responsibilities

Accelerating Translation at Dana-Farber Cancer Institute*

Chief Development Officer National Brain Tumor Society

Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA

Excellence in Trial Management

Working Together to Improve Cancer Outcomes. The American Cancer Society and the American College of Surgeons Commission on Cancer

University of Prince Edward Island PANDEMIC PREPAREDNESS PLAN. October 7, 2009

Update on Federal Activities

Oregon Statewide Tobacco Control Plan. Taking Action for a Tobacco Free Oregon. Year 4/5 Operations Plan

Update on the NCI Cancer Centers Program Henry P. Ciolino, Ph.D. Director, Office of Cancer Centers

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

2018 Addressing Health Disparities Leadership Program. Informational Webinar January 29, 2018

THE TEXAS CANCER PLAN KAREN TORGES CHAIR, CANCER ALLIANCE OF TEXAS

CTA Strengths. Organisational Structure Board. CTA Board CEO. Background to Cancer Trials Australia What we do well An increasing struggle Conclusions

Fighting Cancer with Data: Perspectives on MD Anderson Moon Shot Program

PROGRESS UPDATE. Evan T. Mandeville DIPG Research Fund

Together 2 Goal Innovator Track: Cardiovascular Disease Cohort. Call for Participation

UT Health Physicians. Carlos A. Rosende, M.D., F.A.C.S. Executive Vice Dean for Clinical Affairs Executive Director, UT Health Physicians

Regional Clinical Co-Lead (Physician) Role Opportunity

GREATER FLINT HEALTH COALITION TERMS OF REFERENCE QUALITY & INNOVATION TASK FORCE (2013)

Final Strategic Long-Range Plan

Integrated Cancer Services Plan HNHB LHIN

Oncology Clinical Trials Conference

Prostate Cancer Clinical Trials - PHEN s Rally Update and Next Steps

Opportunity and Challenge

Safe States Alliance & SAVIR Annual Meeting: June 2013

BRINGING ONCOLOGY SPECIALTY CARE TO THE COMMUNITY USING NURSING NAVIGATION

NRG ONCOLOGY SEMIANNUAL MEETING FINAL AGENDA (REVISED) Manchester Grand Hyatt San Diego, California February 5 8, 2015

CPRIT Overview. Cancer Centers Administrators Forum April 4, 2016

2017FACTs. Discover. Care. Believe.

Changing the Clinical Trials System: An NCI Update. Michigan Cancer Consortium Annual Meeting November 5, Marge Good, RN, MPH, OCN

Fall 2018 Research Training Program Agenda. S E S SI ON 1, Tuesday, S eptember 11, 2018

PHARMACY PRACTICE (PHM PRAC)

EORTC : 54 ans de recherche académique. 12ème Biennale Monégasque de Cancérologie 5 février 2016

The Center on Aging unites aging-related research, education, and clinical programs at the University of Utah to help people lead longer and more

Sheila Prindiville, MD, MPH Director Coordinating Center for Clinical Trials National Cancer Institute

Associate Board Description Sheet

NH Oral Health Enhancing the Role of the Public Health Dental Hygienist in 2015

HEMATOLOGY AND ONCOLOGY

YMCA Calgary. Strategic Plan

ALS ACT (Accelerated Therapeutics)

Strategic Plan Executive Summary Society for Research on Nicotine and Tobacco

Research Collaborations: Lessons from PeDRA and the SPD

Retina International General Assembly Auckland, New Zealand

RARE DISEASE. THE POWER OFx. Experts. Experienc e. Execution. Challenges Conducting Rare Disease Studies. Experts: Experience: Execution:

Ministry of Health and Long-Term Care. Palliative Care. Follow-Up on VFM Section 3.08, 2014 Annual Report RECOMMENDATION STATUS OVERVIEW

The Academy Capitol Forum: Meet the Experts. Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved

S ORCE S U R G I C A L O U T C O M E S RESEARCH CENTER

Ruth McCorkle, PhD; Rebecca Kirch, JD; Kim Thiboldeaux; Julie Taylor; and Mark Gorman

London Regional Cancer Program

Request for Applications Basic, Clinical and Population Science Pilot Awards

Here for You When You Need Us

Progress Update June 2017 Lay Summary Funding: $6,000,000 Grant Funded: July 2015 Dream Team Members Dream Team Leader:

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

Phase 2b trial met key clinical objectives and is being discontinued early by the sponsor

Anesthesia Into The Future: A Snapshot DEPARTMENT OF ANESTHESIA, PAIN MANAGEMENT & PERIOPERATIVE MEDICINE STRATEGIC PLAN

Phase I Planning Grant Application. Issued by: Caring for Colorado Foundation. Application Deadline: July 1, 2015, 5:00 PM

62 accc-cancer.org May June 2016 OI

SeniorMed Education Forum 2008 Piecing Together Today s Senior Healthcare Puzzle. May 1, Tampa Marriott Westshore

Key Competencies for the EHS & Sustainability Profession

RESEARCH BUSINESS DEVELOPMENT MANAGER OVARIAN CANCER AUSTRALIA

Transcription:

Alliance Organizational Structure Trini Ajazi, MM Alliance Chief Administrative Officer Clinical Research Professional Orientation May 10, 2017

NCI-NCTN National Cancer Institute (NCI) National Clinical Trials Network (NCTN) is a consolidated, integrated network comprised of organizations that conduct definitive, randomized clinical treatment trials across a broad range of diseases and diverse patient populations 4 Adult Network Groups, 1 Canadian and 1 Pediatric Group that sponsor and lead NCTN trials

NCORP NCI Community Oncology Research Program (NCORP) community based program designed to bring clinical trials to individuals in their own communities and contribute to improved patient outcomes and reduction in cancer disparities NCORP designs and conducts cancer prevention, control, screening, post surveillance and cancer care delivery clinical trials Facilitates access to treatment and imaging trials from NCTN

About the Alliance for Clinical Trials in Oncology National Clinical Trials Network (NCTN) Group consists of nearly 10,000 cancer specialists at approximately 1000 hospitals, medical centers, and community sites across the United States and Canada. Vision: to reduce the impact of cancer by uniting a broad community of scientists and clinicians from many disciplines, committed to discovering, validating and disseminating effective strategies for the prevention and treatment of cancer

Alliance Mission Alliance achieves its purpose by conducting high quality multidisciplinary cancer control, prevention, and treatment trials that engage a comprehensive research network; furthering our understanding of the biological basis of the cancer process and its treatment, from discovery, to validation, to clinical practice; providing a scientific and operational infrastructure for innovative clinical and translational research in academic and community settings

Alliance History Merger of three Groups11 by the merger of three cooperative groups: American College of Surgeons Oncology Group (ACOSOG) Cancer and Leukemia Group B (CALGB) North Central Cancer Treatment Group (NCCTG) Merger initiated in 2011 and completed March 2014 with start of new NCTN grant period The merger of these cooperative groups reflects the call in April 2010 from the Institute of Medicine (IOM) to strengthen and streamline operations among NCI clinical trials cooperative group programs.

Alliance Network Membership Institutions must meet Alliance accrual and performance requirements per Alliance Policies and Procedures Members are academic and community sites, including NCI grant funded Lead Academic Participating Sites (LAPS) and NCI Community Oncology Research Program (NCORP) sites Most studies are available to all NCTN member sites via an open menu

Alliance: Overview of Governance and Program Structure Alliance Board of Directors The Executive Committee represents the Board of Directors and assists the group chair in planning and coordinating group activities. The primary governance body of the Alliance is the Board of Directors, which represents the group s institutional members. The Alliance is also supported by five program directors, each responsible for a specific program integrating disciplinerelated science and operational functions across all disease committees. Director, Statistics & Data Management Program Director, Central Protocol Operations Program Director, Translational Research Program Alliance Group Chair Executive Committee Group Vice Chair Chief Administrative Officer The Alliance is led by the group chair with assistance from the group vice chair. Director, ACS Clinical Research Program Chief Financial Officer Director, Cancer Control Program

Breast Respiratory Genitourinary Gastrointestinal Neuro- Oncology Leukemia Lymphoma Myeloma Scientific Modality/Disciplines Surgical Oncology, Research Program, Transplant, Radiation Oncology, Pathology, Imaging, Oncology Nursing, Clinical Research Professionals, Biostatistics, Bioinformatics, Pharmacology, Pharmacogenomics, Patient Advocates, Health Outcomes, Symptom Intervention, Experimental Therapeutics, Community Oncology, Research Ethics, Laboratory Medicine, Cancer Prevention, Cancer Care Delivery, Young Investigators, Pharmacy Administrative Committees: Board of Directors, Executive Committee Constitution and Bylaws, Membership, Institutional Performance Evaluation, Conflict of Interest, Audit, Publications, Data and Safety Monitoring Board

Alliance Leadership Group Chair: Monica Bertagnolli, MD, Dana-Farber/Brigham Women s Hospital Cancer Center Group Vice Chair: Suzanne George, MD, Dana Farber Cancer Institute Group Statistician/Director SDMP: Sumithra Mandrekar, PhD, Mayo Clinic Director, Central Protocol Operations Program: Gini Fleming, MD, University of Chicago Director, Cancer Control Program: Jan Buckner, MD, Mayo Clinic Director, Translational Research Program, Fraser Symmans, MD, MD Anderson Cancer Center Director American College of Surgeons Clinical Research Program: Kelly Hunt, MD, MD Anderson Cancer Center

Board of Directors lcomprised of 50 Alliance Principal Investigators or institutional representative lresponsible for final approval of overall policy for the Alliance, election of Group Chair, approval of institutional membership. lexecutive Committee reports to the Board of Directors

Executive Committee lled by Group Chair and Group Vice Chair lmembers include the 5 program directors/co-principal investigators and 4 academic BOD representatives and 4 community BOD representatives lrecommends to the Board of Directors overall Alliance policy, direction, priorities, and activities lapproves committee chair and vice chair appointments

Office of the Group Chair Operations Units (located at BWH and UChicago) Group Administration Finance Membership Services and Communications Regulatory Compliance and Quality Assurance Scientific Committees Breast, Gastrointestinal, Genitourinary, Leukemia, Lymphoma, Myeloma, Neuro-oncology, Respiratory, Transplant Patient Advocates, Clinical Research Professionals, Experimental Therapeutics, Oncology Nursing, Radiation Oncology Administrative Committees Audit, Patient Communications, Conflict of Interest, Constitution, DSMB, Ethics Young Investigators, Institutional Performance Evaluation, Membership, Pharmacy, Publications Group Chair and Principal Investigator: Monica M. Bertagnolli, MD - Dana-Farber/Brigham and Women s Cancer Center Group Vice Chair: Suzanne George- Dana Farber Cancer Institute

Statistics and Data Management Operations Units (located at Mayo and Duke) Data Management Systems Management Information Systems Statistics Scientific Committees Biostatistics Bioinformatics Group Statistician and Principal Investigator: Sumithra Mandrekar, PhD - Mayo Clinic Operations Manager: Cari Cummins Mayo Clinic

Central Protocol Operations Operations Units (located at UChicago) Protocol Office (Protocol Development and Management) Pharmaceutical Affairs Scientific Committees Study Concept Review Principal Investigator and Director: Gini F. Fleming, MD - University of Chicago Director of Protocol Operations: Michael Kelly, MA, University of Chicago

Translational Research Program Operations Units (located at MS Anderson, Uchicago, Wash U) Integrated Biorepositories Translational Research Operations Scientific Committees Leukemia Correlative Sciences, Solid Tumor Correlative Science, Imaging, Pharmacogenomic & Population Pharmacology, Pathology, Sequencing Administrative Committees Karotype Review, Biorepositories Principal Investigator and Director: W. Fraser Symmans, MD, MD Anderson Cancer Center Director Biorespositories: Mark Watson, MD, Washington University Director Translational Research Operations: Yujia Wen, PhD, University of Chicago

Cancer Control Program Operations Units (located at Mayo) NCORP Research Base Scientific Committees Cancer in the Elderly, Health Disparities, Health Outcomes, Prevention, Symptom Intervention Community Oncology (Administrative) Principal Investigator and Director: Jan C. Buckner, MD - Mayo Clinic Program Manager: Jacqueline Lafky, MS Mayo Clinic

ACoS Clinical Research Program Operations Units (located at MD Anderson/ACS Chicago) Commission on Cancer National Cancer Database Program Management Scientific Committees Cancer Care Standards Development Cancer Care Delivery Research Dissemination and Implementation Administrative Committees Education Principal Investigator and Director: Kelly Hunt, MD, MD Anderson Cancer Center Program Manager: Amanda Francescatti, MS, American College of Surgeons

Alliance for Clinical Trials in Oncology Foundation Not-for-Profit Corporation created to enhance and expand the ability of Alliance members* to conduct cancer clinical research 501(c)3 Governance and operations structure separate from the Alliance Alliance Foundation Trials, LLC (AFT) LLC (sole member = Foundation) created to conduct cancer clinical research involving partners other than the National Cancer Institute

Study Design by Scientific and Modality Committees Study Operations ALLIANCE NCTN/NCORP

Org Charts

Office of the Group Chair Group Chair Monica Bertagnolli, MD Group Vice-Chair Suzanne George, MD Chief Financial Officer Denise Brennan Chief Administrative Officer Trini Ajazi, MM Grants Administration Administrative Support/Office Management Member Services Finance IT/IS Regulatory Affairs and Compliance Meetings Management Project Management Quality Assurance/Audit Program Communications Training Reporting

Central Protocol Operations Program Principal Investigator/Director Gini Fleming, MD Executive Officers Linda Sluman, MD Selina Chow, MD Priya Kumthekar, MD Pharmaceutical Affairs Manager Ligi Matthews, PharmD Director Translational Research Operations Yujia Wen, PhD Director Protocol Operations Michael Kelly, MA Protocol Information Specialist Clinical Trial Managers Protocol Coordinators Senior Protocol Coordinators

Additional Slides Program Structures and Org Charts

Translational Research Program (TRP) TRP Scientific Advisory Board Biorepository Systems TRP Administrative Core Molecular Reference Laboratories Tissue Collection Biorepository IHC/FISH/PCR Tissue Storage Committee Microarray Specimen Tracking Sequencing Committee Imaging Committee Serum Proteomics Tissue Processing Information Technology Pathology Committee TRP Executive Committee Karyotype Review Pharmacokinetics Pharmacogenomics Sequencing Pharmacogenomics and Population Pharmacology Leukemia Correlative Science Committee

Alliance/American College of Surgeons Clinical Research Program Committee Structure Alliance/American College of Surgeons Clinical Research Program Executive Committee Scientific Committees Administrative Committee Cancer Care Delivery Research Dissemination & Implementation Cancer Care Standards Development Education

Alliance/American College of Surgeons Clinical Research Program Staff Structure Program Director, Clinical Research Program Manager, Clinical Research Program Developer Project Manager

AFT Operations Structure President Chief Scientific Officer Vice President Chief Administrative Officer Chief Financial Officer Chief Operating Officer Quality and Compliance Accounting Administrative Support HR/Office Management QA Support Accounting Support IT/IS Regulatory & Protocol Management Budget & Fiscal Planning Project Management Project Support Sr. Site Management Contracts & Agreements Site Support Contract Support